Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. - Wikidata - wikimedia - TriplyDB

Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.

Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.

http://www.wikidata.org/entity/Q34994966

about

Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of Macedonia Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis.Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest?Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry Physicians' behavior following changes in LDL cholesterol target goals.Kidney disease in people with diabetes: the expanding epidemic.Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997-1999 and 2008-2011.Structured self-management education maintained over two years in insufficiently controlled type 2 diabetes patients: the ERMIES randomised trial in Reunion Island Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE Baseline Antihypertensive Drug Count and Patient Response to Hypertension Medication Management The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.Ambulatory blood pressure monitoring phenotypes among individuals with and without diabetes taking antihypertensive medication: the Jackson Heart Study.Prescription Practice for Diabetes Management among a Female Population in Primary Health Care.Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009.Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease.Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study.Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study.Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA.Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46).Collaborateurs aux lignes directrices en soins primaires: Quelles sont leurs professions et combien sont en conflit d’intérêts?

P2860

Q30585937-03EECFBB-AE19-4B28-8D41-835612ACB490 Q33847033-D56F8A4E-C591-4F8F-87E5-716D13CA14F3 Q34555388-C4589129-465D-4612-9C42-697C93152C2A Q34994802-2ACD0C37-44CA-46DD-B759-CD5C7EE1CB9D Q35165341-9B653E5E-9FF1-422D-9785-9C08B7085EBA Q35590852-DD8EA143-16CB-429C-B5DD-D364B46B1088 Q35669497-9B5FAC4F-590C-41BF-8107-FBBC1D403883 Q35785967-4F2A9A99-8050-4141-8788-4A97D7B7DE1E Q36091640-5DB1A8F2-DF7F-4010-B5C7-5DB13E9D496B Q36200650-BC0A31CA-85AC-412F-8DAF-7DECF8982C50 Q36249641-9934CCBA-F208-4CD2-9311-3096AAFB93BA Q36281537-A69FF1EA-E2B2-4E09-9722-872CE72B4675 Q36301785-4FA439DF-828E-4483-A56E-E0EE84731294 Q36510146-1F971769-CBB3-4E95-9018-2801A8DF0939 Q36510353-C4B4899F-0AA3-4986-8413-2F05BCC4007C Q36689778-9FDCF93B-868E-48C4-B363-C5C01E32888A Q37022665-F1221031-7529-4394-A837-41B486A0D39B Q37277979-C915D023-35AA-4581-AE6F-28F30CDD89C6 Q37682498-21D480D2-C394-4F44-9318-3DA70544C0E5 Q37693629-54A57EB0-B68D-418E-B57D-7C4A2FB45ED3 Q37700758-F5BD81A1-C4F6-4835-9F05-CBC49AB97E71 Q38430611-74FAFF1A-10A3-4CD3-BBC9-6527A527665C Q41636583-C5AB5276-FFC6-4899-B3CD-F9CEBD6992A4 Q42281490-AB416494-9B2D-47D0-B126-4889CA6B3B34 Q43527297-F7D50209-7EC6-4405-90BF-87C0AB314655 Q49105874-C84E0F53-1817-47E2-9A7C-514F2D35FCE6 Q54996163-54BD1129-7540-4256-901E-BF0DD5324D9F Q55241568-8E06D5D6-5366-4782-AFF1-3DF5B6F79605 Q55285074-D33F1278-3FEC-4B1C-B4EB-09AACEA7237E

P2860

Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.

http://www.wikidata.org/entity/Q34994966

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@ast

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@en

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@nl

type

label

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@ast

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@en

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@nl

prefLabel

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@ast

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@en

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@nl

P1433

Q34994966-A55F867D-E4FA-442E-A2C3-AF729ED796BA

P1476

Q34994966-0B117F16-046C-42D1-BBE8-C768B50E81BF

P2093

Q34994966-991F09F1-1249-4A35-A092-894DE25E047C

Q34994966-A256E649-C3B2-4D44-8B9B-9F6C768D347F

P2860

Q34994966-056C13D7-9432-4470-96DE-86BD52781986

Q34994966-0AFDBEAC-5D18-4C7A-8E8C-2231B02C8C4C

Q34994966-0C2E4C8F-9582-493E-9727-4240DAE6AC50

Q34994966-14F4F50D-255F-493D-9BD2-6C99F4575EF7

Q34994966-23B02022-D936-458C-8688-1A4240F384AF

Q34994966-3902689D-B1B2-4989-95CF-479D9A7F46BD

Q34994966-3E24C397-CA09-4571-BC9D-6F248FC1554B

Q34994966-3F036B46-2437-4B68-BA5B-3B10FACF02B1

Q34994966-40249A10-2447-4C7F-8749-DB02E16E200D

Q34994966-4809CE12-C622-4169-B01D-63CBD57B680B

P2888

Q34994966-ACE31F61-A3F8-4CED-B520-39F7C97659C4

P304

Q34994966-E518E397-1AB4-432F-88D3-9070BEFB7D29

P31

Q34994966-0B47A79B-B796-42D6-873B-EE9A7336A02E

P356

Q34994966-3225CC4C-0372-455E-9500-4888E88A148A

P407

Q34994966-A33A6AC4-6282-4C92-BFAD-63569FE30825

P478

Q34994966-B04F9AF2-93D2-4849-B57D-86718B62AD30

P577

Q34994966-500B3D7D-E44D-44BD-8EBB-C72DE5AF1FD4

P5875

Q34994966-2DA9F7FA-41E9-46CB-AC02-EA2CB156DA0B

P6179

Q34994966-E85EBCE0-A876-43B5-A0BD-E83CB8A70E62

P698

Q34994966-AC01F0D0-A25F-4AE7-B208-D8740D52E8B3

P932

Q34994966-6DB9FA65-49CC-4138-B490-109A65483AA8

P356

1475-2840-10-31

P1433

Cardiovascular Diabetology

P1476

Trends in utilization of lipid ...... iabetic population, 1999-2008.

@en

P2093

Andreas Kuznik

http://www.w3.org/2001/XMLSchema#string

Jack Mardekian

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Selecting effective incentive structures in health care: A decision framework to support health care purchasers in finding the right incentives to drive performance.

Standards of medical care in diabetes--2010.

P2888

1475-2840-10-31

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-10-31

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51054302

http://www.w3.org/2001/XMLSchema#string

P6179

1034440859

http://www.w3.org/2001/XMLSchema#string

P698

21496321

http://www.w3.org/2001/XMLSchema#string

P932

3098774

http://www.w3.org/2001/XMLSchema#string